Literature DB >> 12384647

Testing of cerebral endothelium function with L-arginine after stroke.

B Zvan1, M Zaletel, T Pogacnik, T Kiauta.   

Abstract

BACKGROUND: Endothelium-dependent vasodilatation could be impaired during hypoperfusion. L-arginine (L-A), a precursor of nitric oxide, is able to elicit endothelium-dependent vasodilatation. To determine cerebral vascular endothelial function in the early stages after ischemic stroke, we studied cerebrovascular reactivity to L-A with transcranial Doppler (TCD).
METHODS: The study group consisted of 15 patients with the middle cerebral artery syndrome, aged 57.6+/-9.8 years. They were investigated on days 7 to 10 after ischemic stroke. The control group consisted of 15 healthy volunteers, aged 58+/-10.7 years. All subjects received an intravenous infusion of L-A over 20 min at a rate of 1.5 g/min. The mean arterial velocity (vm) was measured in both middle cerebral arteries by using a bitemporal monitoring system (Multi-Dop X4, DWL). At the same time, the mean arterial pressure (MAP) and heart rate (HR) were measured by Finapres and ECG. The end-tidal CO2 (Et-Co2) was monitored by capnograph. The Vm over 5-min intervals at rest and during the infusion of L-A was determined by using the DWL TCD8 software.
RESULTS: The Vm significantly increased in both hemispheres of both groups (p=0.00). Vm differences between rest and L-A stimulation were lower in the ischemic hemispheres compared to the healthy ones (p=0.00), but did not differ between the ischemic hemispheres and hemispheres of the healthy group (p>0.05). MAP, HR and Et-Co2 did not change during the infusion (p>0.05).
CONCLUSIONS: Cerebrovascular reactivity to L-A is impaired in patients with recent stroke. The amino acid could thus be useful in testing endothelium function both in healthy persons and in stroke patients since endothelium dysfunction seems to be an important factor in reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384647

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  8 in total

1.  L-arginine reactivity in cerebral vessels after severe traumatic brain injury.

Authors:  Leonardo Rangel-Castilla; Osama Ahmed; J Clay Goodman; Shankar Gopinath; Alex Valadka; Claudia Robertson
Journal:  Neurol Res       Date:  2010-08-16       Impact factor: 2.448

Review 2.  Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review.

Authors:  Paul Philipp Heinisch; Corina Bello; Maximilian Y Emmert; Thierry Carrel; Martina Dreßen; Jürgen Hörer; Bernhard Winkler; Markus M Luedi
Journal:  Cells       Date:  2022-05-18       Impact factor: 7.666

Review 3.  Mechanisms involved in the cerebrovascular dilator effects of cortical spreading depression.

Authors:  David W Busija; Ferenc Bari; Ferenc Domoki; Takashi Horiguchi; Katsuyoshi Shimizu
Journal:  Prog Neurobiol       Date:  2008-09-12       Impact factor: 11.685

4.  Doppler study of cerebral arteries in hypercholesterolemia.

Authors:  Mehdi Farhoudi; Kaveh Mehrvar; Naser Aslanabadi; Kamyar Ghabili; Nazila Rasi Baghmishe; Farzad Ilkhchoei
Journal:  Vasc Health Risk Manag       Date:  2011-03-31

5.  Associations between cerebral and systemic endothelial function in migraine patients: a post-hoc study.

Authors:  Denis Perko; Janja Pretnar-Oblak; Mišo Šabovič; Marjan Zaletel; Bojana Žvan
Journal:  BMC Neurol       Date:  2011-11-15       Impact factor: 2.474

Review 6.  Cerebral endothelial function determined by cerebrovascular reactivity to L-arginine.

Authors:  Janja Pretnar-Oblak
Journal:  Biomed Res Int       Date:  2014-04-17       Impact factor: 3.411

7.  The Influence of Calcitonin Gene-Related Peptide on Cerebral Hemodynamics in Nonmigraine Subjects with Calcitonin Gene-Related Peptide-Induced Headaches.

Authors:  Matija Zupan; Marjan Zaletel; Darja Visočnik; Bojana Žvan
Journal:  Biomed Res Int       Date:  2021-04-24       Impact factor: 3.411

8.  The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis--a case control pilot study.

Authors:  Matija Zupan; Mišo Šabović; Marjan Zaletel; Katarina Šurlan Popovič; Bojana Žvan
Journal:  BMC Neurol       Date:  2015-09-02       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.